Search clinical trials for: Omaveloxolone
Total 16 results
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedInflammation and Pain Following Ocular SurgeryUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVie; Friedreich's Ataxia Research AllianceActive, not recruitingFriedreich AtaxiaUnited States, Australia, Austria, Italy, United Kingdom
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMItochondrial MyopathiesUnited States, Denmark
-
Reata, a wholly owned subsidiary of BiogenNo longer available
-
Reata, a wholly owned subsidiary of BiogenCompletedHepatic ImpairmentUnited States
-
BiogenNot yet recruiting
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMetastatic or Incurable Non-small Cell Lung Cancer | Relapsed, Refractory MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompleted
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedOcular Inflammation | Ocular Pain | Corneal Endothelial Cell Loss | Cataract SurgeryUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCelerion; Q2 SolutionsCompleted
-
GlaxoSmithKlineUnknown
-
Reata, a wholly owned subsidiary of BiogenCelerion; Q2 Solutions; Altasciences Company Inc.Completed
-
Reata, a wholly owned subsidiary of BiogenCovanceCompletedHealthy Adult SubjectsUnited States